BAP31 deficiency exacerbates LPS-induced microglial activation and neuronal death via IL-1 receptor-associated kinase (IRAK1) [27], and promotes amyloid-β plaque formation in Alzheimer’s disease (AD) mouse model through destabilization of reticulon 3 [28]. This evidence concerns the gene BCAP31 and Alzheimer disease.